Brief: Iconovo And Galenica Enters Strategic Collaboration For Development Of New Inhalation Products

Iconovo AB

02/05/2022 06:32

May 2 (Reuters) - Iconovo AB  ICO.ST :
    * ICONOVO AND GALENICA ENTERS A STRATEGIC COLLABORATION FOR
THE
DEVELOPMENT OF NEW INHALATION PRODUCTS
    * ENTERED INTO A STRATEGIC COLLABORATION WITH GALENICA AB -
A
COMPANY SPECIALIZING IN DEVELOPMENT AND MANUFACTURE OF
PHARMACEUTICALS FOR CLINICAL STUDIES.
    * MAIN PURPOSE OF COLLABORATION IS TO FACILITATE
MANUFACTURING OF
CLINICAL TRIAL MATERIAL FOR COMPANIES DEVELOPING NEW DRUGS FOR
ICONOVO'S INNOVATIVE SINGLE DOSE INHALER ICOONE
    * PLAN IS FOR MANUFACTURING EQUIPMENT TO BE IMPLEMENTED AND
PUT
INTO OPERATION IN AUGUST 2022

Source text for Eikon:  ID:nMFNb1Yc01 
Further company coverage:  ICO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))